Related Experiment Video
Updated: Oct 4, 2025

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Oncogenic Roles of Small Nucleolar RNA Host Gene 7 (SNHG7) Long Noncoding RNA in Human Cancers and Potentials
Sajad Najafi1, Soudeh Ghafouri-Fard2, Bashdar Mahmud Hussen3,4
1Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
Long noncoding RNAs (lncRNAs) are a class of noncoding transcripts characterized with more than 200 nucleotides of length. Unlike their names, some short open reading frames are recognized for them encoding small proteins. LncRNAs are found to play regulatory roles in essential cellular processes such as cell growth and apoptosis. Therefore, an increasing number of lncRNAs are identified with dysregulation in a wide variety of human cancers. SNHG7 is an lncRNA with upregulation in cancer cells and tissues. It is frequently reported with potency of promoting malignant cell behaviors in vitro and in vivo. Like oncogenic/tumor suppressor lncRNAs, SNHG7 is found to exert its tumorigenic functions through interaction with other biological substances. These include sponging target miRNAs (various numbers are identified), regulation of several signaling pathways, transcription factors, and effector proteins. Importantly, clinical studies demonstrate association between high SNHG7 expression and clinicopathological features in cancerous patients, worse prognosis, and enhanced chemoresistance. In this review, we summarize recent studies in three eras of cell, animal, and human experiments to bold the prognostic, diagnostic, and therapeutic potentials.
Insights
The long noncoding RNA SNHG7 promotes cancer progression and is linked to poor prognosis and chemoresistance. This review highlights its potential as a prognostic, diagnostic, and therapeutic target in cancer.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long noncoding RNAs (lncRNAs) are key regulators of cellular processes.
- Dysregulation of lncRNAs, including SNHG7, is implicated in human cancers.
- SNHG7 is frequently upregulated and promotes malignant behaviors.
Purpose of the Study:
- To review recent research on SNHG7 in cancer.
- To explore the prognostic, diagnostic, and therapeutic potential of SNHG7.
Main Methods:
- Literature review of studies across cellular, animal, and human experiments.
- Analysis of SNHG7's molecular mechanisms and clinical associations.
Main Results:
- SNHG7 promotes cancer cell growth, invasion, and metastasis.
- SNHG7 interacts with miRNAs, signaling pathways, and proteins to drive tumorigenesis.
- High SNHG7 expression correlates with adverse clinicopathological features, poor prognosis, and chemoresistance.
Conclusions:
- SNHG7 is a promising biomarker for cancer prognosis and diagnosis.
- Targeting SNHG7 offers potential therapeutic strategies for cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Nucleolus
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Types of RNA
RNA Performs Diverse...

